BR112013012630B1 - Célula de levedura geneticamente modificada, e, método para produzir 3-hp - Google Patents
Célula de levedura geneticamente modificada, e, método para produzir 3-hp Download PDFInfo
- Publication number
- BR112013012630B1 BR112013012630B1 BR112013012630-2A BR112013012630A BR112013012630B1 BR 112013012630 B1 BR112013012630 B1 BR 112013012630B1 BR 112013012630 A BR112013012630 A BR 112013012630A BR 112013012630 B1 BR112013012630 B1 BR 112013012630B1
- Authority
- BR
- Brazil
- Prior art keywords
- gene
- seq
- amino acid
- acid sequence
- exogenous
- Prior art date
Links
- 210000005253 yeast cell Anatomy 0.000 title claims abstract description 120
- 238000000034 method Methods 0.000 title description 54
- 210000004027 cell Anatomy 0.000 claims abstract description 170
- 230000037361 pathway Effects 0.000 claims abstract description 148
- 238000000855 fermentation Methods 0.000 claims abstract description 130
- 230000004151 fermentation Effects 0.000 claims abstract description 130
- 238000004519 manufacturing process Methods 0.000 claims abstract description 35
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 claims description 579
- 108090000623 proteins and genes Proteins 0.000 claims description 478
- 150000001413 amino acids Chemical group 0.000 claims description 193
- 241000235645 Pichia kudriavzevii Species 0.000 claims description 107
- 229920001184 polypeptide Polymers 0.000 claims description 98
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 98
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 98
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 84
- 238000003780 insertion Methods 0.000 claims description 50
- 230000037431 insertion Effects 0.000 claims description 50
- 238000012217 deletion Methods 0.000 claims description 44
- 230000037430 deletion Effects 0.000 claims description 44
- 239000002609 medium Substances 0.000 claims description 44
- 229940000635 beta-alanine Drugs 0.000 claims description 42
- 230000012010 growth Effects 0.000 claims description 39
- 101150006589 adc gene Proteins 0.000 claims description 33
- 101150096049 pyc gene Proteins 0.000 claims description 32
- 230000001105 regulatory effect Effects 0.000 claims description 28
- 108010053763 Pyruvate Carboxylase Proteins 0.000 claims description 27
- 101150023977 Baat gene Proteins 0.000 claims description 25
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 claims description 22
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims description 21
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims description 19
- 101710088194 Dehydrogenase Proteins 0.000 claims description 19
- 108010002447 aspartate-alpha-decarboxylase Proteins 0.000 claims description 19
- 102100026278 Cysteine sulfinic acid decarboxylase Human genes 0.000 claims description 18
- 229910052799 carbon Inorganic materials 0.000 claims description 17
- 101150116670 gabT gene Proteins 0.000 claims description 17
- 241000521553 Pichia fermentans Species 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 101150023641 ppc gene Proteins 0.000 claims description 15
- 101150037054 aat gene Proteins 0.000 claims description 11
- 241000235070 Saccharomyces Species 0.000 claims description 8
- 108090000340 Transaminases Proteins 0.000 claims description 8
- 102000003929 Transaminases Human genes 0.000 claims description 7
- 102100035923 4-aminobutyrate aminotransferase, mitochondrial Human genes 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 6
- 239000007222 ypd medium Substances 0.000 claims description 6
- 101710094518 4-aminobutyrate aminotransferase Proteins 0.000 claims description 5
- 101100229074 Gallus gallus GAL6 gene Proteins 0.000 claims description 4
- 101150046686 LAP3 gene Proteins 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 195
- 239000012634 fragment Substances 0.000 description 153
- 239000000047 product Substances 0.000 description 123
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 122
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 112
- 230000000694 effects Effects 0.000 description 112
- 239000002773 nucleotide Substances 0.000 description 95
- 125000003729 nucleotide group Chemical group 0.000 description 95
- 239000013612 plasmid Substances 0.000 description 95
- 101150050575 URA3 gene Proteins 0.000 description 84
- 102000004190 Enzymes Human genes 0.000 description 69
- 108090000790 Enzymes Proteins 0.000 description 69
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 68
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 67
- 239000000499 gel Substances 0.000 description 65
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 65
- 239000013598 vector Substances 0.000 description 61
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 108020004414 DNA Proteins 0.000 description 58
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 57
- 230000001580 bacterial effect Effects 0.000 description 55
- 239000003550 marker Substances 0.000 description 55
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 51
- 230000014509 gene expression Effects 0.000 description 48
- 239000000872 buffer Substances 0.000 description 42
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 42
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 41
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 41
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 40
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 39
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 38
- 108091026890 Coding region Proteins 0.000 description 36
- 239000008103 glucose Substances 0.000 description 36
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 34
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 34
- 230000010354 integration Effects 0.000 description 32
- 241000588724 Escherichia coli Species 0.000 description 30
- 239000011543 agarose gel Substances 0.000 description 30
- 238000000605 extraction Methods 0.000 description 28
- 239000007795 chemical reaction product Substances 0.000 description 27
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 27
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 27
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 27
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 27
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 27
- 238000001962 electrophoresis Methods 0.000 description 27
- 239000000243 solution Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 108020004530 Transaldolase Proteins 0.000 description 24
- 102100028601 Transaldolase Human genes 0.000 description 24
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 24
- -1 hexose sugars Chemical class 0.000 description 24
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 23
- 108010093796 4-hydroxybutyrate dehydrogenase Proteins 0.000 description 23
- 239000008051 TBE buffer Substances 0.000 description 23
- 230000029087 digestion Effects 0.000 description 23
- 108020003281 3-hydroxyisobutyrate dehydrogenase Proteins 0.000 description 22
- 239000004310 lactic acid Substances 0.000 description 21
- 235000014655 lactic acid Nutrition 0.000 description 21
- 102000006027 3-hydroxyisobutyrate dehydrogenase Human genes 0.000 description 20
- 108090001042 Hydro-Lyases Proteins 0.000 description 20
- 239000000543 intermediate Substances 0.000 description 20
- 230000035772 mutation Effects 0.000 description 20
- 238000012216 screening Methods 0.000 description 20
- 238000011144 upstream manufacturing Methods 0.000 description 20
- 238000004458 analytical method Methods 0.000 description 19
- 108010008386 malonyl-Coa reductase Proteins 0.000 description 19
- 108090000489 Carboxy-Lyases Proteins 0.000 description 18
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 18
- 239000002253 acid Substances 0.000 description 18
- 229940009098 aspartate Drugs 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 18
- 241000894007 species Species 0.000 description 18
- 108010018763 Biotin carboxylase Proteins 0.000 description 17
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 17
- 101150031265 PCK gene Proteins 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 16
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 16
- 108090000364 Ligases Proteins 0.000 description 16
- 108090000472 Phosphoenolpyruvate carboxykinase (ATP) Proteins 0.000 description 16
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 16
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 16
- 229940049920 malate Drugs 0.000 description 16
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 16
- 150000007524 organic acids Chemical class 0.000 description 16
- 101150034686 PDC gene Proteins 0.000 description 15
- 239000007983 Tris buffer Substances 0.000 description 15
- 230000003321 amplification Effects 0.000 description 15
- 108010072869 indolepyruvate decarboxylase Proteins 0.000 description 15
- 238000003199 nucleic acid amplification method Methods 0.000 description 15
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 15
- 108010077268 3-hydroxyisobutyryl-CoA hydrolase Proteins 0.000 description 14
- SEHFUALWMUWDKS-UHFFFAOYSA-N 5-fluoroorotic acid Chemical compound OC(=O)C=1NC(=O)NC(=O)C=1F SEHFUALWMUWDKS-UHFFFAOYSA-N 0.000 description 14
- POODSGUMUCVRTR-IEXPHMLFSA-N acryloyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C=C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 POODSGUMUCVRTR-IEXPHMLFSA-N 0.000 description 14
- 230000002538 fungal effect Effects 0.000 description 14
- 235000000346 sugar Nutrition 0.000 description 14
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 13
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 13
- 239000008049 TAE buffer Substances 0.000 description 13
- 108090000992 Transferases Proteins 0.000 description 13
- 102000014701 Transketolase Human genes 0.000 description 13
- 108010043652 Transketolase Proteins 0.000 description 13
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 13
- 238000010276 construction Methods 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 230000002068 genetic effect Effects 0.000 description 13
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 13
- 108010031025 Alanine Dehydrogenase Proteins 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- 102000004031 Carboxy-Lyases Human genes 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000008188 pellet Substances 0.000 description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 11
- 241001468227 Streptomyces avermitilis Species 0.000 description 11
- 235000004279 alanine Nutrition 0.000 description 11
- RUWSXZUPLIXLGD-IEXPHMLFSA-N beta-alanyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCN)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RUWSXZUPLIXLGD-IEXPHMLFSA-N 0.000 description 11
- 235000010633 broth Nutrition 0.000 description 11
- 238000010367 cloning Methods 0.000 description 11
- 239000011535 reaction buffer Substances 0.000 description 11
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 10
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 10
- 108010082126 Alanine transaminase Proteins 0.000 description 10
- 102100036431 Calcineurin subunit B type 1 Human genes 0.000 description 10
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 10
- 241000238631 Hexapoda Species 0.000 description 10
- 101000714321 Homo sapiens Calcineurin subunit B type 1 Proteins 0.000 description 10
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 10
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000000246 agarose gel electrophoresis Methods 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 108010025593 phenylalanine (histidine) aminotransferase Proteins 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 108030006993 Beta-alanyl-CoA ammonia-lyases Proteins 0.000 description 9
- 101150087048 CYB2 gene Proteins 0.000 description 9
- 108010058076 D-xylulose reductase Proteins 0.000 description 9
- 102000004867 Hydro-Lyases Human genes 0.000 description 9
- 108090000604 Hydrolases Proteins 0.000 description 9
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 9
- 102000003960 Ligases Human genes 0.000 description 9
- 108090000854 Oxidoreductases Proteins 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 229940093915 gynecological organic acid Drugs 0.000 description 9
- 238000002744 homologous recombination Methods 0.000 description 9
- 230000006801 homologous recombination Effects 0.000 description 9
- 101150108412 kgd gene Proteins 0.000 description 9
- 108010067653 lactate dehydratase Proteins 0.000 description 9
- 235000005985 organic acids Nutrition 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 102100034767 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial Human genes 0.000 description 8
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 8
- 102000016912 Aldehyde Reductase Human genes 0.000 description 8
- 108010053754 Aldehyde reductase Proteins 0.000 description 8
- 108010005694 Aspartate 4-decarboxylase Proteins 0.000 description 8
- 108010071778 Benzoylformate decarboxylase Proteins 0.000 description 8
- 101100439285 Candida albicans (strain SC5314 / ATCC MYA-2876) CLB4 gene Proteins 0.000 description 8
- 102000004157 Hydrolases Human genes 0.000 description 8
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 8
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 8
- 102000004357 Transferases Human genes 0.000 description 8
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
- 108010007014 alanine 2,3-aminomutase Proteins 0.000 description 8
- VIWKEBOLLIEAIL-FBMOWMAESA-N lactoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VIWKEBOLLIEAIL-FBMOWMAESA-N 0.000 description 8
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 7
- 239000002028 Biomass Substances 0.000 description 7
- 241000186226 Corynebacterium glutamicum Species 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 101150050255 PDC1 gene Proteins 0.000 description 7
- 230000002378 acidificating effect Effects 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 229910052737 gold Inorganic materials 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 7
- 238000002703 mutagenesis Methods 0.000 description 7
- 231100000350 mutagenesis Toxicity 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- OAKURXIZZOAYBC-UHFFFAOYSA-N 3-oxopropanoic acid Chemical compound OC(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-N 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 6
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 101100351264 Candida albicans (strain SC5314 / ATCC MYA-2876) PDC11 gene Proteins 0.000 description 6
- 101000705592 Cucumis melo Phytoene synthase, chloroplastic Proteins 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- 102000012410 DNA Ligases Human genes 0.000 description 6
- 108010061982 DNA Ligases Proteins 0.000 description 6
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 6
- 101710088791 Elongation factor 2 Proteins 0.000 description 6
- 108010025885 Glycerol dehydratase Proteins 0.000 description 6
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 6
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 6
- 229910013594 LiOAc Inorganic materials 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 102000004316 Oxidoreductases Human genes 0.000 description 6
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 108091081024 Start codon Proteins 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 101710205823 Translation elongation factor 2 Proteins 0.000 description 6
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 6
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 6
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 6
- 235000019253 formic acid Nutrition 0.000 description 6
- 238000012239 gene modification Methods 0.000 description 6
- 230000005017 genetic modification Effects 0.000 description 6
- 235000013617 genetically modified food Nutrition 0.000 description 6
- 230000002414 glycolytic effect Effects 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 108010017192 4-hydroxy-4-methyl-2-oxoglutarate aldolase Proteins 0.000 description 5
- OPIFSICVWOWJMJ-YGEXGZRRSA-N 5-bromo-4-chloro-3-indolyl alpha-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-YGEXGZRRSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- 102100029589 Acylpyruvase FAHD1, mitochondrial Human genes 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 5
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 5
- 238000001712 DNA sequencing Methods 0.000 description 5
- 101710195328 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex Proteins 0.000 description 5
- 101150035384 HIBADH gene Proteins 0.000 description 5
- 241000235644 Issatchenkia Species 0.000 description 5
- 108030004530 Malonate-semialdehyde dehydrogenases Proteins 0.000 description 5
- 241000157876 Metallosphaera sedula Species 0.000 description 5
- 101150019587 PDH gene Proteins 0.000 description 5
- 241000589540 Pseudomonas fluorescens Species 0.000 description 5
- 241000191043 Rhodobacter sphaeroides Species 0.000 description 5
- 108020001027 Ribosomal DNA Proteins 0.000 description 5
- 241000503309 Sceloporus bulleri Species 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000001952 enzyme assay Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 5
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 241000194108 Bacillus licheniformis Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 241000235087 Lachancea kluyveri Species 0.000 description 4
- 108091000076 Lysine 2,3-aminomutase Proteins 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 101710104378 Putative malate oxidoreductase [NAD] Proteins 0.000 description 4
- 101100161407 Rhodococcus erythropolis aam gene Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 101150098232 YMR226C gene Proteins 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000013599 cloning vector Substances 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 4
- 230000037353 metabolic pathway Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 101150043391 mmsB gene Proteins 0.000 description 4
- 101150076071 panD gene Proteins 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000006152 selective media Substances 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 229940035893 uracil Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 108010021680 2-oxoglutarate decarboxylase Proteins 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241000316922 Caldicoprobacter faecalis Species 0.000 description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- 241000192731 Chloroflexus aurantiacus Species 0.000 description 3
- 241000193401 Clostridium acetobutylicum Species 0.000 description 3
- 241000193468 Clostridium perfringens Species 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 101150038242 GAL10 gene Proteins 0.000 description 3
- 101150022730 MEL5 gene Proteins 0.000 description 3
- 108090000301 Membrane transport proteins Proteins 0.000 description 3
- 241001302042 Methanothermobacter thermautotrophicus Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 3
- 241000235062 Pichia membranifaciens Species 0.000 description 3
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 3
- 241000589776 Pseudomonas putida Species 0.000 description 3
- 241001148115 Rhizobium etli Species 0.000 description 3
- 244000253911 Saccharomyces fragilis Species 0.000 description 3
- 241000589196 Sinorhizobium meliloti Species 0.000 description 3
- 108010084631 acetolactate decarboxylase Proteins 0.000 description 3
- LDHQLWOKXNHSSJ-ICWQEWPPSA-N azane;[(2e)-3,7-dimethylocta-2,6-dienyl] phosphono hydrogen phosphate Chemical compound N.N.N.CC(C)=CCC\C(C)=C\COP(O)(=O)OP(O)(O)=O LDHQLWOKXNHSSJ-ICWQEWPPSA-N 0.000 description 3
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 3
- 238000009739 binding Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012411 cloning technique Methods 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 238000006114 decarboxylation reaction Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 229940120503 dihydroxyacetone Drugs 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000006481 glucose medium Substances 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 3
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003839 salts Chemical group 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000001384 succinic acid Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 3
- 229940045145 uridine Drugs 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- 108020005065 3' Flanking Region Proteins 0.000 description 2
- RSTKLPZEZYGQPY-UHFFFAOYSA-N 3-(indol-3-yl)pyruvic acid Chemical compound C1=CC=C2C(CC(=O)C(=O)O)=CNC2=C1 RSTKLPZEZYGQPY-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 2
- 101150051977 AAT2 gene Proteins 0.000 description 2
- 241000023308 Acca Species 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 101100480861 Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) tdh gene Proteins 0.000 description 2
- 101100447466 Candida albicans (strain WO-1) TDH1 gene Proteins 0.000 description 2
- 241000023502 Clostridium kluyveri DSM 555 Species 0.000 description 2
- 241001528539 Cupriavidus necator Species 0.000 description 2
- 102100030497 Cytochrome c Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108700036404 EC 1.1.1.298 Proteins 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 102100024637 Galectin-10 Human genes 0.000 description 2
- 101150019065 HBD gene Proteins 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 101001046426 Homo sapiens cGMP-dependent protein kinase 1 Proteins 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 241000235649 Kluyveromyces Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 241000604448 Megasphaera elsdenii Species 0.000 description 2
- 102000003939 Membrane transport proteins Human genes 0.000 description 2
- 101100242684 Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) panD1 gene Proteins 0.000 description 2
- 241000589195 Mesorhizobium loti Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 2
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 241000481518 Ralstonia eutropha H16 Species 0.000 description 2
- 108700003422 S. cerevisiae UGA1 Proteins 0.000 description 2
- 101001000154 Schistosoma mansoni Phosphoglycerate kinase Proteins 0.000 description 2
- 241000235346 Schizosaccharomyces Species 0.000 description 2
- 240000000878 Spathiostemon javensis Species 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
- 241000235006 Torulaspora Species 0.000 description 2
- 102100037116 Transcription elongation factor 1 homolog Human genes 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 108010084455 Zeocin Proteins 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 241000235017 Zygosaccharomyces Species 0.000 description 2
- 101150013885 accB gene Proteins 0.000 description 2
- 101150070497 accC gene Proteins 0.000 description 2
- 101150008263 accD gene Proteins 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 2
- 102000005840 alpha-Galactosidase Human genes 0.000 description 2
- 108010030291 alpha-Galactosidase Proteins 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000012224 gene deletion Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000002500 ions Chemical group 0.000 description 2
- 108010046473 iso-2-cytochrome C Proteins 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 101150104734 ldh gene Proteins 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 101150040445 lpd gene Proteins 0.000 description 2
- 101150080950 mdlC gene Proteins 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 108091027963 non-coding RNA Proteins 0.000 description 2
- 102000042567 non-coding RNA Human genes 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 101150086832 pdhC gene Proteins 0.000 description 2
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 101150088047 tdh3 gene Proteins 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 101150090985 ydfG gene Proteins 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- XKHGLWVOOXPLCK-UHFFFAOYSA-N 2-(1h-indol-2-yl)acetaldehyde Chemical compound C1=CC=C2NC(CC=O)=CC2=C1 XKHGLWVOOXPLCK-UHFFFAOYSA-N 0.000 description 1
- NMDWGEGFJUBKLB-UHFFFAOYSA-M 2-acetyllactate Chemical compound CC(=O)C(C)(O)C([O-])=O NMDWGEGFJUBKLB-UHFFFAOYSA-M 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VOKUMXABRRXHAR-UHFFFAOYSA-N 2-methyl-3-oxopropanoic acid Chemical compound O=CC(C)C(O)=O VOKUMXABRRXHAR-UHFFFAOYSA-N 0.000 description 1
- FECNVDHIIJYRIA-UHFFFAOYSA-N 2-oxopentanedioic acid Chemical compound OC(=O)CCC(=O)C(O)=O.OC(=O)CCC(=O)C(O)=O FECNVDHIIJYRIA-UHFFFAOYSA-N 0.000 description 1
- DBXBTMSZEOQQDU-UHFFFAOYSA-N 3-hydroxyisobutyric acid Chemical compound OCC(C)C(O)=O DBXBTMSZEOQQDU-UHFFFAOYSA-N 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 description 1
- 108030001569 3-hydroxypropionate dehydrogenases Proteins 0.000 description 1
- 108030005924 3-hydroxypropionyl-CoA dehydratases Proteins 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 108010060511 4-Aminobutyrate Transaminase Proteins 0.000 description 1
- 108030000921 4-aminobutyrate-2-oxoglutarate transaminases Proteins 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- ACNXXUCYLYKAPB-UHFFFAOYSA-N 5-bromo-6-pyrrolidin-1-yl-1h-pyrimidine-2,4-dione Chemical compound OC1=NC(O)=C(Br)C(N2CCCC2)=N1 ACNXXUCYLYKAPB-UHFFFAOYSA-N 0.000 description 1
- LODRRYMGPWQCTR-UHFFFAOYSA-N 5-fluoro-2,4-dioxo-1h-pyrimidine-6-carboxylic acid;hydrate Chemical compound O.OC(=O)C=1NC(=O)NC(=O)C=1F LODRRYMGPWQCTR-UHFFFAOYSA-N 0.000 description 1
- 101150058703 ACC1 gene Proteins 0.000 description 1
- 241000589212 Acetobacter pasteurianus Species 0.000 description 1
- 241000948980 Actinobacillus succinogenes Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 244000300657 Alchornea rugosa Species 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000722954 Anaerobiospirillum succiniciproducens Species 0.000 description 1
- 241001136167 Anaerotignum propionicum Species 0.000 description 1
- 241001244729 Apalis Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 108030003579 Aspartate 1-decarboxylases Proteins 0.000 description 1
- 102100034193 Aspartate aminotransferase, mitochondrial Human genes 0.000 description 1
- 108030002081 Aspartate transaminases Proteins 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101100378010 Bacillus subtilis (strain 168) accC1 gene Proteins 0.000 description 1
- 101100322122 Bacillus subtilis (strain 168) accC2 gene Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000149420 Bothrometopus brevis Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 108030003513 Branched-chain-2-oxoacid decarboxylases Proteins 0.000 description 1
- 241000130699 Branchiostoma japonicum Species 0.000 description 1
- 241000228092 Candida entomophila Species 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 241000186570 Clostridium kluyveri Species 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 1
- 101100499356 Dictyostelium discoideum lpd gene Proteins 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 101150053890 EDA gene Proteins 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 241000190842 Erythrobacter sp. Species 0.000 description 1
- 101000596984 Escherichia coli (strain K12) PFL-like enzyme TdcE Proteins 0.000 description 1
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 101150079046 GAL6 gene Proteins 0.000 description 1
- QGWNDRXFNXRZMB-UUOKFMHZSA-K GDP(3-) Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O QGWNDRXFNXRZMB-UUOKFMHZSA-K 0.000 description 1
- 101150064643 GPD gene Proteins 0.000 description 1
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 1
- 101710162684 Glyceraldehyde-3-phosphate dehydrogenase 3 Proteins 0.000 description 1
- 102000057621 Glycerol kinases Human genes 0.000 description 1
- 108700016170 Glycerol kinases Proteins 0.000 description 1
- 102100038261 Glycerol-3-phosphate phosphatase Human genes 0.000 description 1
- 101710171812 Glycerol-3-phosphate phosphatase Proteins 0.000 description 1
- 108010015895 Glycerone kinase Proteins 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000028523 Hereditary Complement Deficiency disease Diseases 0.000 description 1
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 241000171379 Kazachstania bulderi Species 0.000 description 1
- 241000512931 Kazachstania humilis Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241001480034 Kodamaea ohmeri Species 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical group C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 101150007280 LEU2 gene Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102100024032 Linker for activation of T-cells family member 1 Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical class Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241000207738 Maritalea mobilis Species 0.000 description 1
- 101100456321 Metallosphaera sedula (strain ATCC 51363 / DSM 5348 / JCM 9185 / NBRC 15509 / TH2) Msed_0709 gene Proteins 0.000 description 1
- 101100381816 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) bkdC gene Proteins 0.000 description 1
- 101150095445 NAP1 gene Proteins 0.000 description 1
- 102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
- 101150026476 PAO1 gene Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 208000012204 PDA1 Diseases 0.000 description 1
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 1
- 240000003388 Parartocarpus venenosus Species 0.000 description 1
- 108090000645 Phosphoenolpyruvate carboxykinase (GTP) Proteins 0.000 description 1
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 1
- 241000521509 Pichia deserticola Species 0.000 description 1
- 241000517333 Pichia manshurica Species 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 241000186334 Propionibacterium freudenreichii subsp. shermanii Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 241001240958 Pseudomonas aeruginosa PAO1 Species 0.000 description 1
- 241000320117 Pseudomonas putida KT2440 Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 241000516658 Roseiflexus castenholzii Species 0.000 description 1
- 239000012722 SDS sample buffer Substances 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 101100462087 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) LAT1 gene Proteins 0.000 description 1
- 101100027944 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PDB1 gene Proteins 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 101150094640 Siae gene Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000203644 Streptoalloteichus hindustanus Species 0.000 description 1
- 241000938061 Streptomyces thermophilus Species 0.000 description 1
- 241000160715 Sulfolobus tokodaii Species 0.000 description 1
- 101100009687 Synechocystis sp. (strain PCC 6803 / Kazusa) lpdA gene Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 241000235034 Zygosaccharomyces bisporus Species 0.000 description 1
- 241000400042 Zygosaccharomyces kombuchaensis Species 0.000 description 1
- 241001655839 Zygosaccharomyces lentus Species 0.000 description 1
- 241000192381 [Candida] diddensiae Species 0.000 description 1
- 241000509461 [Candida] ethanolica Species 0.000 description 1
- 241000228120 [Candida] vanderwaltii Species 0.000 description 1
- 241000029538 [Mannheimia] succiniciproducens Species 0.000 description 1
- DTPIAWSSVGTUPF-UHFFFAOYSA-N [Mo].[Na].[Na] Chemical compound [Mo].[Na].[Na] DTPIAWSSVGTUPF-UHFFFAOYSA-N 0.000 description 1
- 101150069122 aam gene Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 101150015189 aceE gene Proteins 0.000 description 1
- 101150077561 aceF gene Proteins 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 101150067366 adh gene Proteins 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 101150055425 aldh gene Proteins 0.000 description 1
- 150000004716 alpha keto acids Chemical class 0.000 description 1
- 101150072110 alt2 gene Proteins 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229940126574 aminoglycoside antibiotic Drugs 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 101150005925 aspC gene Proteins 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 101150103637 bkdB gene Proteins 0.000 description 1
- 101150038738 ble gene Proteins 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 108010036467 butanediol dehydrogenase Proteins 0.000 description 1
- 102100022422 cGMP-dependent protein kinase 1 Human genes 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 101150107471 dpgB gene Proteins 0.000 description 1
- 230000005014 ectopic expression Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 108010008221 formate C-acetyltransferase Proteins 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108010032776 glycerol-1-phosphatase Proteins 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- QGWNDRXFNXRZMB-UHFFFAOYSA-N guanidine diphosphate Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O QGWNDRXFNXRZMB-UHFFFAOYSA-N 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 229940116871 l-lactate Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- LTYOQGRJFJAKNA-VFLPNFFSSA-N malonyl-coa Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-VFLPNFFSSA-N 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- YLJRCXSSKLWCDE-UHFFFAOYSA-N methyl ethanesulfonate Chemical compound CCS(=O)(=O)OC YLJRCXSSKLWCDE-UHFFFAOYSA-N 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 101150102492 pda1 gene Proteins 0.000 description 1
- 101150028177 pdhB gene Proteins 0.000 description 1
- 101150015354 pdhD gene Proteins 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 101150035767 trp gene Proteins 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/52—Propionic acid; Butyric acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
- C12Y206/01001—Aspartate transaminase (2.6.1.1), i.e. aspartate-aminotransferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01059—3-Hydroxypropionate dehydrogenase (1.1.1.59)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
- C12Y206/01018—Beta-alanine-pyruvate transaminase (2.6.1.18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
- C12Y206/01019—4-Aminobutyrate—2-oxoglutarate transaminase (2.6.1.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01031—Phosphoenolpyruvate carboxylase (4.1.1.31)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41619910P | 2010-11-22 | 2010-11-22 | |
| US61/416,199 | 2010-11-22 | ||
| US61/416199 | 2010-11-22 | ||
| US201161535181P | 2011-09-15 | 2011-09-15 | |
| US61/535181 | 2011-09-15 | ||
| US61/535,181 | 2011-09-15 | ||
| PCT/US2011/061717 WO2012074818A2 (en) | 2010-11-22 | 2011-11-21 | Compositions and methods for 3-hydroxypropionic acid production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013012630A2 BR112013012630A2 (pt) | 2020-09-24 |
| BR112013012630B1 true BR112013012630B1 (pt) | 2021-09-08 |
Family
ID=45099210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013012630-2A BR112013012630B1 (pt) | 2010-11-22 | 2011-11-21 | Célula de levedura geneticamente modificada, e, método para produzir 3-hp |
Country Status (11)
| Country | Link |
|---|---|
| US (7) | US9090918B2 (enExample) |
| EP (2) | EP3287519B1 (enExample) |
| JP (1) | JP6061862B2 (enExample) |
| KR (1) | KR20130119945A (enExample) |
| CN (2) | CN107828671B (enExample) |
| AU (1) | AU2011336923B2 (enExample) |
| BR (1) | BR112013012630B1 (enExample) |
| CA (1) | CA2818499A1 (enExample) |
| MX (1) | MX2013005654A (enExample) |
| WO (1) | WO2012074818A2 (enExample) |
| ZA (1) | ZA201303544B (enExample) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101442910A (zh) | 2006-03-13 | 2009-05-27 | 卡吉尔公司 | 具有从磷酸二羟丙酮到甘油的途径被破坏的酵母细胞 |
| WO2012019175A2 (en) | 2010-08-06 | 2012-02-09 | Mascoma Corporation | Production of malonyl-coa drived products via anaerobic pathways |
| BR112013012130A2 (pt) * | 2010-11-22 | 2017-10-31 | Cargill Inc | composições e métodos para titulação aumentada de etanol a partir de biomassa |
| JP6061862B2 (ja) | 2010-11-22 | 2017-01-18 | カーギル,インコーポレイティド | 3‐ヒドロキシプロピオン酸生産用の組成物及び方法 |
| EP2725895A1 (en) * | 2011-06-28 | 2014-05-07 | Brookhaven Science Associates LLC | Modified plants with increased oil content |
| BR112014004190A2 (pt) * | 2011-08-24 | 2017-03-01 | Novozymes Inc | método para construir uma cepa fúngida filamentosa, cepa fúngida filamentosa, método para produzir múltiplos polipeptídeos recombinantes, e, construto em tandem |
| IN2014CN03187A (enExample) | 2011-09-30 | 2015-07-03 | Novozymes Inc | |
| AU2013230930B2 (en) * | 2012-03-06 | 2018-10-11 | Lygos, Inc. | Recombinant host cells for the production of malonate |
| WO2013180581A1 (en) * | 2012-05-30 | 2013-12-05 | Lanzatech New Zealand Limited | Recombinant microorganisms and uses therefor |
| CA2881666A1 (en) | 2012-08-10 | 2014-02-13 | Opx Biotechnologies, Inc. | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
| WO2014057036A1 (en) | 2012-10-11 | 2014-04-17 | Technical University Of Denmark | Genetically engineered yeast |
| AU2013352418B2 (en) | 2012-11-30 | 2016-12-08 | Novozymes, Inc. | 3-Hydroxypropionic Acid production by recombinant yeasts |
| US9441250B2 (en) * | 2013-03-14 | 2016-09-13 | Butamax Advanced Biofuels Llc | Glycerol 3- phosphate dehydrogenase for butanol production |
| US20150044746A1 (en) * | 2013-03-15 | 2015-02-12 | Opx Biotechnologies, Inc. | Method of enhanced bioproduction |
| JP2016518821A (ja) | 2013-03-15 | 2016-06-30 | カーギル・インコーポレイテッド | 3−ヒドロキシプロピオン酸の回収 |
| US9447438B2 (en) | 2013-03-15 | 2016-09-20 | Cargill, Incorporated | Acetyl-coA carboxylases |
| EP3008178A1 (en) | 2013-06-14 | 2016-04-20 | Technical University of Denmark | Microbial production of 3-hydroxypropionic acid |
| US10077455B2 (en) | 2013-06-14 | 2018-09-18 | Technical University Of Denmark | 3HP tolerance |
| US11408013B2 (en) | 2013-07-19 | 2022-08-09 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
| US9556443B2 (en) | 2013-07-19 | 2017-01-31 | Samsung Electronics Co., Ltd. | Yeast cell with inactivated NADH dehydrogenase and method of producing lactate using the yeast cell |
| BR112016001026A2 (pt) | 2013-07-19 | 2017-10-24 | Cargill Inc | organismo geneticamente modificado |
| DK3027733T3 (en) | 2013-07-31 | 2018-12-10 | Novozymes As | Preparation of 3-Hydroxypropionic Acid in Recombinant Yeast Expressing an Insect Aspartate-1 Decarboxylase |
| WO2015031504A1 (en) * | 2013-08-27 | 2015-03-05 | The Regents Of The University Of California | RECOMBINANT PATHWAY AND ORGANISMS FOR MALONYL-CoA SYNTHESIS |
| WO2015036273A1 (de) | 2013-09-12 | 2015-03-19 | Basf Se | Verfahren zur herstellung von acrylsäure |
| US10252970B2 (en) | 2013-09-12 | 2019-04-09 | Basf Se | Method of dehydrating 3-hydroxypropionic acid to form acrylic acid |
| US9630900B2 (en) | 2013-09-12 | 2017-04-25 | Basf Se | Method for the dehydration of 3-hydroxypropanoic acid to form acrylic acid |
| WO2015076393A1 (ja) | 2013-11-22 | 2015-05-28 | 旭硝子株式会社 | 形質転換体およびその製造方法、ならびに乳酸の製造方法 |
| JP6515502B2 (ja) * | 2013-11-22 | 2019-05-22 | Agc株式会社 | 形質転換体の製造方法、形質転換体、および単座組込み用ベクターキット |
| KR101555867B1 (ko) | 2014-04-18 | 2015-10-01 | 부산대학교 산학협력단 | 3-하이드록시프로피온산을 분해하지 않는 슈도모나스 데니트리피칸스 결실 변이균주 및 이를 이용한 3-하이드록시프로피온산의 생산방법 |
| EP3161142A4 (en) * | 2014-06-26 | 2018-05-16 | Lygos, Inc. | Recombinant host cells for the production of malonate |
| WO2016026763A1 (en) | 2014-08-18 | 2016-02-25 | Basf Se | Process for preparing acrylic acid using a heterogeneous alumina catalyst |
| US10704064B2 (en) * | 2014-08-29 | 2020-07-07 | Sk Innovation Co., Ltd. | Recombinant yeast producing 3-hydroxypropionic acid and method for producing 3-hydroxypropionic acid using the same |
| EP2993228B1 (en) | 2014-09-02 | 2019-10-09 | Cargill, Incorporated | Production of fatty acid esters |
| US10214754B2 (en) | 2014-10-10 | 2019-02-26 | Jmtc Enzyme Corporation | Transformant and its production process, and method for producing lactic acid |
| WO2016100910A1 (en) * | 2014-12-19 | 2016-06-23 | Novozymes A/S | Recombinant host cells for the production of 3-hydroxypropionic acid |
| CN107109347A (zh) * | 2014-12-19 | 2017-08-29 | 诺维信公司 | 用于生产3‑羟基丙酸的重组宿主细胞 |
| WO2016135020A1 (de) | 2015-02-24 | 2016-09-01 | Basf Se | Verfahren zur kontinuierlichen dehydratisierung von 3-hydroxypropionsäure zu acrylsäure |
| DK3262161T3 (da) * | 2015-02-27 | 2021-09-13 | Novozymes As | Rekombinante værtsceller til fremstilling af 3-hydroxypropionsyre |
| WO2016162175A1 (de) | 2015-04-07 | 2016-10-13 | Basf Se | Verfahren zur dehydratisierung von 3-hydroxypropionsäure zu acrylsäure |
| EP3321364B1 (en) | 2015-06-11 | 2022-12-28 | Noroo IC Co., Ltd. | Promoter system inducing expression by 3-hydroxypropionic acid and method for biological production of 3-hydroxypropionic acid using same |
| WO2016200239A1 (ko) * | 2015-06-11 | 2016-12-15 | 부산대학교 산학협력단 | 3-하이드록시프로피온산에 의해 발현이 유도되는 프로모터 시스템 및 이를 이용한 3-하이드록시프로피온산의 생물학적 생산방법 |
| JP2018519829A (ja) * | 2015-07-21 | 2018-07-26 | ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント | 1,3−ブタンジオールの産生のための方法および微生物 |
| US20180265902A1 (en) | 2015-08-24 | 2018-09-20 | Novozymes A/S | Beta-Alanine Aminotransferases For The Production of 3-Hydroxypropionic Acid |
| US20180258437A1 (en) * | 2015-11-12 | 2018-09-13 | Lygos, Inc. | Recombinant host cells and methods for the production of l-aspartate and beta-alanine |
| CN109072172A (zh) * | 2015-11-12 | 2018-12-21 | 利戈斯股份有限公司 | 用于厌氧产生L-天冬氨酸和β-丙氨酸的重组宿主细胞和方法 |
| DE102016114555A1 (de) | 2016-08-05 | 2018-02-08 | Thyssenkrupp Ag | Prozess zur Herstellung von Acrylsäure aus einer wässrigen 3-Hydroxypropanol-Lösung |
| WO2018106792A1 (en) | 2016-12-06 | 2018-06-14 | Novozymes A/S | Improved processes for production of ethanol from xylose-containing cellulosic substrates using engineered yeast strains |
| US11345938B2 (en) | 2017-02-02 | 2022-05-31 | Cargill, Incorporated | Genetically modified cells that produce C6-C10 fatty acid derivatives |
| WO2018220116A1 (en) | 2017-05-31 | 2018-12-06 | Novozymes A/S | Xylose fermenting yeast strains and processes thereof for ethanol production |
| WO2018222990A1 (en) | 2017-06-02 | 2018-12-06 | Novozymes A/S | Improved yeast for ethanol production |
| JP7222977B2 (ja) | 2017-08-17 | 2023-02-15 | ビーエーエスエフ ソシエタス・ヨーロピア | アクリル酸-n-ブチルエステルまたはアクリル酸イソブチルエステルの連続的製造方法 |
| CA3073989A1 (en) | 2017-08-29 | 2019-03-07 | Novozymes A/S | Baker's yeast expressing anti-staling/freshness amylases |
| CA3089135A1 (en) | 2018-01-29 | 2019-08-01 | Novozymes A/S | Microorganisms with improved nitrogen utilization for ethanol production |
| KR102419608B1 (ko) * | 2018-02-08 | 2022-07-08 | 주식회사 엘지화학 | 고농도 3-하이드록시프로피온산 수용액의 제조 방법 |
| CN112166197A (zh) | 2018-05-31 | 2021-01-01 | 诺维信公司 | 用于增强酵母生长和生产力的方法 |
| WO2020005834A1 (en) * | 2018-06-25 | 2020-01-02 | Lygos, Inc. | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF ASPARTIC ACID AND β-ALANINE |
| EP3827088A1 (en) | 2018-07-25 | 2021-06-02 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
| BR112021006692A2 (pt) | 2018-10-08 | 2021-08-10 | Novozymes A/S | levedura expressando enzimas para produção de etanol |
| JP7370587B2 (ja) * | 2018-10-30 | 2023-10-30 | GreenEarthInstitute株式会社 | 有機化合物の製造方法およびコリネ型細菌 |
| US11377671B2 (en) | 2018-12-18 | 2022-07-05 | Braskem S.A. | Co-production pathway for 3-HPA and acetyl-CoA derivatives from malonate semialdehyde |
| CN109852605A (zh) * | 2019-01-16 | 2019-06-07 | 徐州工程学院 | 一种诱变筛选高产3-羟基丙酸菌株的方法 |
| CA3143381A1 (en) | 2019-07-26 | 2021-02-04 | Novozymes A/S | Microorganisms with improved nitrogen transport for ethanol production |
| CN112390855B (zh) * | 2019-07-31 | 2022-04-29 | 上海交通大学医学院附属仁济医院 | Pretide-146a在制备缓解或治疗自身免疫性疾病的药物中的应用 |
| BR112022002203A2 (pt) | 2019-08-05 | 2022-09-06 | Novozymes As | Misturas de enzimas e processos para produção de um ingrediente alimentar com alto teor de proteína a partir de um subproduto de vinhaça completa |
| CA3143527A1 (en) | 2019-08-06 | 2021-02-11 | Novozymes A/S | Fusion proteins for improved enzyme expression |
| US12275967B2 (en) | 2019-09-16 | 2025-04-15 | Novozymes A/S | Processes for producing fermentation products and compositions used therein |
| AU2020402990A1 (en) | 2019-12-10 | 2022-06-09 | Novozymes A/S | Microorganism for improved pentose fermentation |
| WO2021163030A2 (en) | 2020-02-10 | 2021-08-19 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| EP4171773B1 (de) | 2020-06-29 | 2024-07-10 | Basf Se | Vorrichtung zur durchführung von stoffaustauschprozessen |
| CN115956123A (zh) * | 2020-07-31 | 2023-04-11 | 株式会社Lg化学 | 两步制备3-羟基丙酸的方法 |
| CN111985041B (zh) * | 2020-09-17 | 2021-03-30 | 青岛理工大学 | 一种加固边坡挡墙高度确定方法及加固边坡挡墙 |
| EP4222136A4 (en) * | 2020-09-30 | 2025-02-26 | Genomium, Inc. | FERMENTATION PROCESS FOR THE PRODUCTION OF BIOACROLEIN AND BIOACRYLIC ACID |
| US10947552B1 (en) | 2020-09-30 | 2021-03-16 | Alpine Roads, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
| US10894812B1 (en) | 2020-09-30 | 2021-01-19 | Alpine Roads, Inc. | Recombinant milk proteins |
| IL301396A (en) | 2020-09-30 | 2023-05-01 | Nobell Foods Inc | Recombinant milk proteins and food compositions comprising the same |
| BR112023008361A2 (pt) | 2020-11-02 | 2023-12-12 | Novozymes As | Variantes de glucoamilase e polinucleotídeos codificando as mesmas |
| EP4242312A4 (en) * | 2020-11-05 | 2024-04-24 | Lg Chem, Ltd. | MICROORGANISMS HAVING THE CAPACITY TO PRODUCE 3-HYDROXYPROPIONIC ACID FROM GLUCOSE AND THEIR USES |
| EP4242319A4 (en) * | 2020-11-05 | 2024-05-22 | Lg Chem, Ltd. | PROCESS FOR PRODUCING 3-HYDROXYPROPIONIC ACID |
| KR102725416B1 (ko) | 2021-02-08 | 2024-11-04 | 란자테크, 인크. | 재조합 미생물 및 이의 용도 |
| EP4352241A1 (en) | 2021-06-07 | 2024-04-17 | Novozymes A/S | Engineered microorganism for improved ethanol fermentation |
| FR3125040B1 (fr) | 2021-07-09 | 2024-04-26 | Snf Sa | Procédé d’obtention de bio-monomère à partir de diméthylaminoethanol d’origine renouvelable |
| FR3125042B1 (fr) | 2021-07-09 | 2024-04-12 | Snf Sa | Procédé d’obtention d’alkyl(méth)acrylamide substitué biosourcé |
| FR3125048B1 (fr) | 2021-07-09 | 2024-04-19 | Snf Sa | Polymère biosourcé à biodégradabilité améliorée |
| WO2023168233A1 (en) | 2022-03-03 | 2023-09-07 | Cargill, Incorporated | Genetically modified yeast and fermentation processes for the production of 3-hydroxypropionate |
| WO2023168244A1 (en) | 2022-03-03 | 2023-09-07 | Cargill, Incorporated | Genetically modified yeast and fermentation processes for the production of 3-hydroxypropionate |
| CN115595328A (zh) * | 2022-03-07 | 2023-01-13 | 中国科学院微生物研究所(Cn) | 天冬氨酸脱羧酶在发酵生产维生素b5中的应用 |
| CN116024184B (zh) * | 2022-07-26 | 2024-03-15 | 南京科技职业学院 | 醛脱氢酶突变体及其在制备5-羟甲基-2-呋喃甲酸中的应用 |
| WO2024137704A2 (en) | 2022-12-19 | 2024-06-27 | Novozymes A/S | Processes for producing fermentation products using fiber-degrading enzymes with engineered yeast |
| WO2024226289A1 (en) | 2023-04-26 | 2024-10-31 | Cargill, Incorporated | Methods for producing propionic acid |
| WO2024258820A2 (en) | 2023-06-13 | 2024-12-19 | Novozymes A/S | Processes for producing fermentation products using engineered yeast expressing a beta-xylosidase |
| WO2025058922A1 (en) | 2023-09-15 | 2025-03-20 | Cargill, Incorporated | Rising film evaporator clean-in-place method and system |
| KR20250119485A (ko) * | 2024-01-31 | 2025-08-07 | 주식회사 엘지화학 | 3-하이드록시프로피온산의 생산 방법 |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL39710A (en) | 1972-06-19 | 1975-04-25 | Imi Inst For Res & Dev | Recovery of acids from aqueous solutions by solvent extraction |
| US4771001A (en) | 1986-03-27 | 1988-09-13 | Neurex Corp. | Production of lactic acid by continuous fermentation using an inexpensive raw material and a simplified method of lactic acid purification |
| US5210296A (en) | 1990-11-19 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Recovery of lactate esters and lactic acid from fermentation broth |
| US5132456A (en) | 1991-05-07 | 1992-07-21 | The Regents Of The University Of California | Sorption of carboxylic acid from carboxylic salt solutions at PHS close to or above the pKa of the acid, with regeneration with an aqueous solution of ammonia or low-molecular-weight alkylamine |
| US5420304A (en) | 1992-03-19 | 1995-05-30 | Biopak Technology, Ltd. | Method to produce cyclic esters |
| AT398982B (de) | 1993-02-18 | 1995-02-27 | Vogelbusch Gmbh | Verfahren zur abtrennung und reinigung von milchsäure |
| US5510526A (en) | 1993-06-29 | 1996-04-23 | Cargill, Incorporated | Lactic acid production, separation and/or recovery process |
| IL109003A (en) | 1994-03-16 | 1999-09-22 | Yissum Res Dev Co | Process and extractant composition for extracting water-soluble carboxylic and mineral acids |
| IT1294728B1 (it) | 1997-09-12 | 1999-04-12 | Biopolo S C A R L | Ceppi di lievito per la riproduzione di acido lattico |
| WO1999053035A1 (en) | 1998-04-13 | 1999-10-21 | The University Of Georgia Research Foundation, Inc. | Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells |
| JP5042407B2 (ja) * | 1998-08-04 | 2012-10-03 | メタボリックス,インコーポレイテッド | ポリオールからのポリヒドロキシアルカノエートの産生 |
| HUP0201204A3 (en) | 1999-05-21 | 2004-07-28 | Cargill Dow Llc Minnetonka | Methods and materials for synthesis of organic products |
| US6852517B1 (en) | 1999-08-30 | 2005-02-08 | Wisconsin Alumni Research Foundation | Production of 3-hydroxypropionic acid in recombinant organisms |
| DE60030403D1 (de) | 1999-08-30 | 2006-10-12 | Wisconsin Alumni Res Found | Herstellung von 3-hydroxypropionsäure in rekombinanten organismen |
| JP4098455B2 (ja) | 2000-03-10 | 2008-06-11 | 株式会社日立製作所 | マーク画像中の電子透かし情報の参照方法及び計算機 |
| AR031480A1 (es) * | 2000-11-20 | 2003-09-24 | Cargill Inc | Acido 3-hidroxipropionico y otros compuestos organicos |
| CA2430270A1 (en) | 2000-11-22 | 2002-05-30 | Cargill Dow Polymers, Llc | Methods and materials for the synthesis of organic products |
| WO2003049525A2 (en) | 2001-11-23 | 2003-06-19 | Cargill Dow Llc | Methods and materials for the production of organic products in cells of $i(candida) species |
| EP1575881B1 (en) | 2002-01-18 | 2009-05-27 | Novozymes A/S | Alanine 2,3- aminomutase |
| CN100577626C (zh) | 2002-03-25 | 2010-01-06 | 嘉吉有限公司 | 制造α,β-不饱和羧酸或其衍生物的方法 |
| UA80976C2 (en) | 2002-05-30 | 2007-11-26 | Cargill Dow Llc | Processes and materials for production of d-lactic acid in yeast |
| EP1556320B1 (en) | 2002-11-01 | 2015-05-13 | Novozymes A/S | Process for preparation of 1,3-propanediol |
| WO2004076398A1 (en) | 2003-02-24 | 2004-09-10 | Cargill Incorporated | Process for preparing 3-hydroxycarboxylic acids |
| ES2329042T3 (es) | 2003-06-26 | 2009-11-20 | Novozymes A/S | Procedimiento para separar y recuperar acido 3-hidroxipropionico y acido acrilico. |
| US20060149100A1 (en) | 2003-06-26 | 2006-07-06 | Xiangsheng Meng | Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
| US7326557B2 (en) | 2003-11-14 | 2008-02-05 | Rice University | Increasing intracellular NADPH availability in E. coli |
| ATE543873T1 (de) * | 2003-12-04 | 2012-02-15 | Novozymes As | Herstellung von 3-hydroxypropionsäure mittels beta-alanine-pyruvat-aminotrransferase |
| EP2292750A3 (en) | 2004-07-30 | 2011-12-21 | Novozymes A/S | Alanine 2, 3 aminomutases |
| US7987056B2 (en) | 2004-09-20 | 2011-07-26 | The Regents Of The University Of Colorado, A Body Corporate | Mixed-library parallel gene mapping quantitative micro-array technique for genome-wide identification of trait conferring genes |
| EP1805304A2 (en) | 2004-10-25 | 2007-07-11 | Codexis, Inc. | Improved alanine 2,3-aminomutases and related polynucleotides |
| PL1760156T3 (pl) | 2005-08-10 | 2013-05-31 | Univ Florida | Materiały i sposoby wydajnej produkcji kwasu mlekowego |
| US7846688B2 (en) | 2005-08-15 | 2010-12-07 | The Regents Of The University Of Colorado | Broad host range vectors for shotgun and expression library cloning in Gram negative bacteria |
| DE102005048818A1 (de) * | 2005-10-10 | 2007-04-12 | Degussa Ag | Mikrobiologische Herstellung von 3-Hydroxypropionsäure |
| CN101442910A (zh) * | 2006-03-13 | 2009-05-27 | 卡吉尔公司 | 具有从磷酸二羟丙酮到甘油的途径被破坏的酵母细胞 |
| US7842485B2 (en) | 2006-03-15 | 2010-11-30 | The Regents Of The University Of Colorado | Enhanced alcohol tolerant microorganism and methods of use thereof |
| US20080103060A1 (en) | 2006-08-08 | 2008-05-01 | Regents Of The University Of Colorado | Compositions and methods for chemical reporter vectors |
| US8030045B2 (en) * | 2006-08-30 | 2011-10-04 | Cargill, Incorporated | Beta-alanine/alpha-ketoglutarate aminotransferase for 3-hydroxypropionic acid production |
| US8938765B2 (en) | 2006-12-22 | 2015-01-20 | Time Warner Cable Enterprises Llc | Methods, apparatus and user interface for providing content on demand |
| WO2008089102A2 (en) | 2007-01-12 | 2008-07-24 | Regents Of The University Of Colorado | Compositions and methods for enhancing tolerance for the production of organic chemicals produced by microorganisms |
| US8673601B2 (en) | 2007-01-22 | 2014-03-18 | Genomatica, Inc. | Methods and organisms for growth-coupled production of 3-hydroxypropionic acid |
| US8048624B1 (en) | 2007-12-04 | 2011-11-01 | Opx Biotechnologies, Inc. | Compositions and methods for 3-hydroxypropionate bio-production from biomass |
| CA2709490A1 (en) | 2007-12-19 | 2009-07-09 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| WO2009089457A1 (en) | 2008-01-11 | 2009-07-16 | Novozymes A/S | Methods for producing 3-hydroxypropionic acid and compounds thereof |
| BRPI0915749A2 (pt) | 2008-07-08 | 2018-07-10 | Opx Biotechnologies Inc | métodos, composições e sistemas para produção biossintética de 1,4-butanodiol |
| US20100021978A1 (en) | 2008-07-23 | 2010-01-28 | Genomatica, Inc. | Methods and organisms for production of 3-hydroxypropionic acid |
| CA2731509A1 (en) * | 2008-07-23 | 2010-01-28 | Opx Biotechnologies, Inc. | Methods, systems and compositions for increased microorganism tolerance to and production of 3-hydroxypropionic acid (3-hp) |
| US20110281314A1 (en) | 2008-08-04 | 2011-11-17 | Lynch Michael D | Methods, systems and compositions related to microbial bio-production of butanol and/or isobutanol |
| WO2010031083A2 (en) | 2008-09-15 | 2010-03-18 | Opx Biotechnologies, Inc. | Methods, systems and compositions related to reduction of conversions of microbially produced 3-hydroxypropionic acid (3-hp) to aldehyde metabolites |
| WO2010059424A2 (en) | 2008-11-18 | 2010-05-27 | Novozymes, Inc. | Methods and compositions for degrading cellulosic material |
| US20110144377A1 (en) | 2009-06-16 | 2011-06-16 | E. I. Du Pont Nemours And Company | Process for the biological production of 3-hydroxypropionic acid with high yield |
| US8809027B1 (en) | 2009-09-27 | 2014-08-19 | Opx Biotechnologies, Inc. | Genetically modified organisms for increased microbial production of 3-hydroxypropionic acid involving an oxaloacetate alpha-decarboxylase |
| MX2012003604A (es) | 2009-09-27 | 2012-09-12 | Opx Biotechnologies Inc | Metodo para producir acido 3-hidroxipropionico y otros productos. |
| CN102597228A (zh) | 2009-10-23 | 2012-07-18 | 诺维信股份有限公司 | 纤维二糖水解酶变体及编码其的多核苷酸 |
| CN102666847B (zh) | 2009-10-29 | 2015-12-09 | 诺维信股份有限公司 | 具有纤维二糖水解酶活性的多肽和编码该多肽的多核苷酸 |
| US20110125118A1 (en) | 2009-11-20 | 2011-05-26 | Opx Biotechnologies, Inc. | Production of an Organic Acid and/or Related Chemicals |
| WO2011094457A1 (en) | 2010-01-27 | 2011-08-04 | Opx Biotechnologies, Inc. | Microorganism production of high-valve chemical products, and related compositions, methods and systems |
| ES2636216T3 (es) | 2010-03-30 | 2017-10-05 | Novozymes North America, Inc. | Procesos de producción de un producto de fermentación |
| US9353391B2 (en) | 2010-08-12 | 2016-05-31 | Novozymes, Inc. | Compositions comprising a polypeptide having cellulolytic enhancing activity and a nitrogen-containing compound and uses thereof |
| JP6061862B2 (ja) * | 2010-11-22 | 2017-01-18 | カーギル,インコーポレイティド | 3‐ヒドロキシプロピオン酸生産用の組成物及び方法 |
| US20140121118A1 (en) | 2010-11-23 | 2014-05-01 | Opx Biotechnologies, Inc. | Methods, systems and compositions regarding multiplex construction protein amino-acid substitutions and identification of sequence-activity relationships, to provide gene replacement such as with tagged mutant genes, such as via efficient homologous recombination |
| WO2013192453A1 (en) | 2012-06-20 | 2013-12-27 | Opx Biotechnologies, Inc. | Purification of 3-hydroxypropionic acid from crude cell broth and dehydration to acrylic acid |
| US20130345470A1 (en) | 2012-06-20 | 2013-12-26 | Opx Biotechnologies, Inc. | Purification of 3-Hydroxypropionic Acid from Crude Cell Broth and Production of Acrylamide |
| WO2014145334A1 (en) | 2013-03-15 | 2014-09-18 | Opx Biotechnologies, Inc. | Acetyl-coa carboxylase mutations |
| US9447438B2 (en) | 2013-03-15 | 2016-09-20 | Cargill, Incorporated | Acetyl-coA carboxylases |
| JP2016518821A (ja) | 2013-03-15 | 2016-06-30 | カーギル・インコーポレイテッド | 3−ヒドロキシプロピオン酸の回収 |
| CA2905602A1 (en) | 2013-03-15 | 2014-09-18 | Sarah M. Hoyt | Flash evaporation for product purification and recovery |
| US20150044746A1 (en) | 2013-03-15 | 2015-02-12 | Opx Biotechnologies, Inc. | Method of enhanced bioproduction |
-
2011
- 2011-11-21 JP JP2013540104A patent/JP6061862B2/ja active Active
- 2011-11-21 US US13/301,556 patent/US9090918B2/en active Active
- 2011-11-21 EP EP17190408.9A patent/EP3287519B1/en active Active
- 2011-11-21 BR BR112013012630-2A patent/BR112013012630B1/pt active IP Right Grant
- 2011-11-21 CN CN201711043999.8A patent/CN107828671B/zh active Active
- 2011-11-21 CN CN201180065738.0A patent/CN103502432A/zh active Pending
- 2011-11-21 WO PCT/US2011/061717 patent/WO2012074818A2/en not_active Ceased
- 2011-11-21 CA CA2818499A patent/CA2818499A1/en not_active Abandoned
- 2011-11-21 EP EP11791715.3A patent/EP2643450A2/en not_active Withdrawn
- 2011-11-21 AU AU2011336923A patent/AU2011336923B2/en active Active
- 2011-11-21 KR KR1020137015983A patent/KR20130119945A/ko not_active Ceased
- 2011-11-21 MX MX2013005654A patent/MX2013005654A/es unknown
-
2013
- 2013-05-15 ZA ZA2013/03544A patent/ZA201303544B/en unknown
- 2013-11-06 US US14/073,441 patent/US20140065681A1/en not_active Abandoned
-
2016
- 2016-03-03 US US15/060,036 patent/US9777280B2/en active Active
-
2017
- 2017-08-28 US US15/688,436 patent/US10260072B2/en active Active
-
2019
- 2019-04-15 US US16/384,150 patent/US10633664B2/en active Active
-
2020
- 2020-04-23 US US16/857,119 patent/US11118187B2/en active Active
-
2021
- 2021-09-13 US US17/473,058 patent/US12054721B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012074818A3 (en) | 2012-09-27 |
| US20140065681A1 (en) | 2014-03-06 |
| BR112013012630A2 (pt) | 2020-09-24 |
| WO2012074818A2 (en) | 2012-06-07 |
| US9090918B2 (en) | 2015-07-28 |
| US10633664B2 (en) | 2020-04-28 |
| MX2013005654A (es) | 2013-07-17 |
| ZA201303544B (en) | 2014-11-26 |
| CN107828671B (zh) | 2022-03-08 |
| EP2643450A2 (en) | 2013-10-02 |
| CN103502432A (zh) | 2014-01-08 |
| AU2011336923B2 (en) | 2017-02-16 |
| CA2818499A1 (en) | 2012-06-07 |
| US20160177317A1 (en) | 2016-06-23 |
| US20190249181A1 (en) | 2019-08-15 |
| US20220064654A1 (en) | 2022-03-03 |
| AU2011336923A1 (en) | 2013-05-30 |
| US20180044684A1 (en) | 2018-02-15 |
| US10260072B2 (en) | 2019-04-16 |
| EP3287519A1 (en) | 2018-02-28 |
| US12054721B2 (en) | 2024-08-06 |
| US20200291408A1 (en) | 2020-09-17 |
| JP6061862B2 (ja) | 2017-01-18 |
| US20120135481A1 (en) | 2012-05-31 |
| US9777280B2 (en) | 2017-10-03 |
| US11118187B2 (en) | 2021-09-14 |
| JP2013542747A (ja) | 2013-11-28 |
| EP3287519B1 (en) | 2020-03-18 |
| KR20130119945A (ko) | 2013-11-01 |
| CN107828671A (zh) | 2018-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12054721B2 (en) | Compositions and methods for 3-hydroxypropionic acid production | |
| US20230193299A1 (en) | Compositions and methods for succinate production | |
| CN105209626B (zh) | 通过重组酵母生产3-羟基丙酸 | |
| CN105431520A (zh) | 利用表达昆虫天冬氨酸1-脱羧酶的重组酵母的3-羟基丙酸生产 | |
| JP7566748B2 (ja) | フルクトース利用の向上のために改変した微生物株 | |
| WO2021133722A1 (en) | Fermentation pathway for producing malonic acid | |
| US20160068872A1 (en) | Compositions and methods for malate and fumarate production | |
| US20130309736A1 (en) | Compositions and methods for malate and fumarate production | |
| US20230295671A1 (en) | Enzymes and methods for production of malonic acid and derivatives thereof | |
| US20230272440A1 (en) | Enzymes and methods for production of malonic acid and derivatives thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B09W | Correction of the decision to grant [chapter 9.1.4 patent gazette] |
Free format text: O PEDIDO TEVE UM PARECER DE DEFERIMENTO NOTIFICADO NA RPI NO 2633 DE 22/06/2021, TENDO SIDO CONSTATADO QUE ESTA NOTIFICACAO FOI EFETUADA COM INCORRECOES NO QUADRO 1 DO PARECER DE DEFERIMENTO |
|
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/11/2011, OBSERVADAS AS CONDICOES LEGAIS. |